Dr. Joanna Sale is a clinical epidemiologist whose current interests are in evidence-to-care gaps in musculoskeletal conditions, medication use, the patient perspective, older adults with multiple chronic diseases and models of behaviour change. While her main area of research is in osteoporosis (patients with osteoporotic or fragility fractures), she is also involved in projects related to pain, osteoarthritis, rheumatoid arthritis, diabetes, asthma and Parkinson’s Disease.
Dr. Sale conducts both quantitative and qualitative research. Her program of research includes studies that examine topics such as patients’ understanding of risk, how patients navigate the health care system, patients’ experiences of the clinical encounter and how patients manage their health care condition in a real world setting. She works predominantly in a bone health environment within the Ministry of Health and Long-Term Care (MOHLTC)-funded Osteoporosis Strategy, a chronic disease management strategy that has been funded since 2005.
Dr. Sale obtained her Masters of Science from the University of British Columbia, her Doctor of Philosophy from McMaster University and her Post-Doctorate from the University of Toronto.
Additional research specialties: Musculoskeletal Health and Outcomes Research.
Please note: Dr. Sale is taking summer students interested in health services and clinical research.
1. Sale JEM, Frankel L, Thielke S, Funnell L. Pain and fracture-related limitations persist beyond six months after a fragility fracture. Rheumatology International, in press.
2. Sale JEM, Cameron C, Thielke S, Meadows L, Senior K. The theory of planned behavior explains intentions to use antiresorptive medication after a fragility fracture. Rheumatology International 2017. DOI:10.1007/s00296-017-3712-7.
3. Sale JEM, Ashe MC, Beaton D, Bogoch E, Frankel L. Men’s health-seeking behaviours regarding bone health after a fragility fracture: A secondary analysis of qualitative data. Osteoporosis International 2016;27(10):3113-3119.
4. Sale JEM. An open letter to The BMJ editors on qualitative research. BMJ 2016;352:i563.
5. Sale JEM, Gignac MA, Hawker G, Beaton D, Frankel L, Bogoch E, Elliot-Gibson V. Patients do not have a consistent understanding of high risk for future fracture: A qualitative study of patients from a post-fracture secondary prevention program. Osteoporosis International 2016;27(1):65-73.
6. Sale JEM, Bogoch E, Meadows L, Gignac M, Frankel L, Inrig T, Beaton D, Jain R. Bone mineral density reporting underestimates fracture risk in Ontario. Health 2015;7:566-571.
7. Sale JEM, Jain R, Akilan K, Senior K, Beaton D, Bogoch E, Boire G, Beaulieu M-C, Lightfoot D, Funnell L. What do we know about individuals who are assessed as moderate risk for future fracture? A scoping review. Health 2015;7:514-520.
8. Sale JEM, Amin M, Carrasco-Labra A, Brignardello-Petersen R, Glick M, Guyatt GH, Azarpazhooh A. A practical approach to evidence-based dentistry: VIII. How to appraise an article based on a qualitative study. Journal of the American Dental Association 2015;146(8):623-630.
9. Sale JEM, Hawker G, Cameron C, Bogoch E, Jain R, Beaton D, Jaglal S, Funnell L. Perceived messages about bone health after a fracture are not consistent across health care providers. Rheumatology International 2015;35(1):97-103.
10. Sale JEM, Bogoch E, Hawker G, Gignac M, Beaton D, Jaglal S, Frankel L. Patient perceptions of provider barriers to post-fracture secondary prevention. Osteoporosis International 2014;25(11):2581-2589.
Click here for a full listing of Dr. Sale’s publications.